Key facts, as of
As of November 5, 2026, Elevance Health (ELV) trades at $432.00, up 35.8% over the past year. Its 52-week range runs from $274.84 to $450.69; the price is 4.1% below that high. It is 23.8% below its all-time high of $567.26, reached in September 2024. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +295.6%, against +316.3% for the S&P 500 (SPY). It sits 15.7% above its 200-day average of $373.35, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 28.6% annualized, which we rate medium risk. It has a trailing P/E of 18.4 and a dividend yield of 1.58%.
Cite: Portfolio Terminal, "Elevance Health (ELV) stock analysis", 2026-11-05. https://portfolio-terminal.com/analyse/elv
Where it trades today
trading 89% of the way up its 52-week range
How the price has moved
How far it is from its record
Elevance Health (ELV) is 23.8% below its all-time high of $567.26, reached in September 2024. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +295.6%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- ELV closes above its 50-day average ($412.34), and the 50-day sits above the 200-day ($373.35): on both averages the chart reads as an uptrend.
- At $432.00, ELV is 4.1% below its 1-year high of $450.69, set on October 21, 2026, and 57.2% above its 1-year low of $274.84 (March 9, 2026).
- Over the past month ELV rose 8.0%, from $400.09 to $432.00.
- ELV trades at 18.4x its last twelve months of earnings and 14.3x the next twelve months' estimate, so analysts expect earnings 29.3% higher.
- Its P/E is 21.1% below the 23.4x median of the 3 other healthcare plans companies we track (UNH, CVS, HUM).
- ELV's 30-day volatility, 28.6% a year, works out to a typical daily move of about 1.8%.
- Yahoo Finance puts its beta at 0.63: over five years of monthly returns, ELV moved about 0.63% for each 1% move of the S&P 500.
- The last session traded 1.6x ELV's average daily volume of the 30 sessions before it.
What would change the read
- A close under the 50-day average, $412.34 (−4.6% from the last close), would turn the read to a pullback; under the 200-day, $373.35 (−13.6%), the longer rise is in question.
- A close above $450.69 (+4.3%) would be a new 1-year high; below $274.84 (−36.4%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for ELV, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under healthcare plans among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for ELV by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for ELV. Last refresh: Nov 6, 2026, 4:23 AM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Healthcare Plans.
What Elevance Health does
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services,…
Employees
96,129
Industry
Healthcare Plans
Headquarters
Indianapolis, United States
What analysts expect
ELV carries a buy consensus from 21 analysts, with an average price target of $482.38 versus $432.00 today (+11.7%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
ELV generated $201.83B in trailing revenue (1.4% year over year), with a 2.5% net margin, and $7.99B of free cash flow, supported by $7.09B of net cash.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $199.13B | — | — | $5.66B | $25.65 | $3.17B |
| 2024 | $176.81B | — | — | $5.98B | $26.29 | $4.55B |
| 2023 | $171.34B | — | — | $5.99B | $25.69 | $6.76B |
| 2022 | $156.59B | — | — | $5.89B | $25.32 | $7.25B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
ELV is in 16 of the 54 ETFs we track. It weighs most in XLV: 1.45% of the fund, holding #19 of 62.
Famous investors who hold it
ELV is in the latest 13F of 2 of the 15 famous investors we follow. Seth Klarman (Baupost Group) holds the most of it: 9.11% of the portfolio, position #2 of 23, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
ELV beside the other companies Yahoo Finance files under healthcare plans among the assets we track (UNH, CVS, HUM, largest first).
ELVyou are here$432.00$93.69B
UNHUnitedHealth Group$395.72$354.57B
CVSCVS Health Corporation$81.33$104.06B
HUMHumana Inc.$411.79$49.45BWhat the chart is saying
In an uptrend, 4.1% under its 1-year high with no resistance above.
uptrend- Price is 4.8% above its 50-day average and 15.7% above its 200-day.
- RSI at 57 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $427.08 (-1.1%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is ELV valued right now?
Elevance Health trades at 18.4 times its last twelve months of earnings and 14.3 times the next twelve months' estimate (Yahoo Finance, November 5, 2026). On the chart: in an uptrend, 4.1% under its 1-year high with no resistance above. Price is 4.8% above its 50-day average and 15.7% above its 200-day.
What is the risk level of ELV?
Based on 30-day volatility of 28.6%, ELV has MEDIUM risk. Its beta of 0.63 means it has swung less than the S&P 500 over the last five years.
Does ELV pay dividends?
Yes, Elevance Health has a dividend yield of 1.58%.
How far is ELV from its all-time high?
Elevance Health is 23.8% below its all-time high of $567.26, reached in September 2024. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +295.6%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold ELV?
16 of the 54 popular ETFs we track hold Elevance Health. The largest weights: XLV (1.45%), VIG (0.36%), VYM (0.35%), VTV (0.31%) and RSP (0.22%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is ELV?
0.12%, as of September 30, 2026: ELV is holding #139 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $1.25 in Elevance Health.
Which famous investors own ELV?
Seth Klarman (9.11% of Baupost Group's 13F) and Renaissance Technologies (0.11% of Founded by Jim Simons's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for ELV?
The average analyst price target for Elevance Health (ELV) is $482.38 based on 21 analyst estimates, about 11.7% above the current price of $432.00. The published range runs from $406.00 to $523.00.
How much revenue does ELV generate?
Elevance Health reported $201.83B in trailing twelve-month revenue. Revenue growth is running at 1.4% year over year. Net margin sits at 2.5%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare ELV with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.